These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22491051)

  • 1. Second malignant neoplasms in testicular cancer survivors.
    Fung C; Fossa SD; Beard CJ; Travis LB
    J Natl Compr Canc Netw; 2012 Apr; 10(4):545-56. PubMed ID: 22491051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary malignant neoplasms in testicular cancer survivors.
    Curreri SA; Fung C; Beard CJ
    Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
    Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
    J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
    J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-associated leukemia following testicular cancer.
    Travis LB; Andersson M; Gospodarowicz M; van Leeuwen FE; Bergfeldt K; Lynch CF; Curtis RE; Kohler BA; Wiklund T; Storm H; Holowaty E; Hall P; Pukkala E; Sleijfer DT; Clarke EA; Boice JD; Stovall M; Gilbert E
    J Natl Cancer Inst; 2000 Jul; 92(14):1165-71. PubMed ID: 10904090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma.
    Scaradavou A; Heller G; Sklar CA; Ren L; Ghavimi F
    Cancer; 1995 Nov; 76(10):1860-7. PubMed ID: 8625059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of testicular cancer and the development of secondary malignancies.
    Bokemeyer C; Schmoll HJ
    J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignant neoplasms and cardiovascular disease following radiotherapy.
    Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
    J Natl Cancer Inst; 2012 Mar; 104(5):357-70. PubMed ID: 22312134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
    van Leeuwen FE; Ng AK
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
    Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
    J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased pancreatic cancer risk following radiotherapy for testicular cancer.
    Hauptmann M; Børge Johannesen T; Gilbert ES; Stovall M; van Leeuwen FE; Rajaraman P; Smith SA; Weathers RE; Aleman BM; Andersson M; Curtis RE; Dores GM; Fraumeni JF; Hall P; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Lynch CF; Pukkala E; Storm HH; Vaalavirta L; van den Belt-Dusebout AW; Morton LM; Fossa SD; Travis LB
    Br J Cancer; 2016 Sep; 115(7):901-8. PubMed ID: 27599043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
    Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
    J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment.
    Rubino C; Adjadj E; Guérin S; Guibout C; Shamsaldin A; Dondon MG; Valteau-Couanet D; Hartmann O; Hawkins M; de Vathaire F
    Int J Cancer; 2003 Dec; 107(5):791-6. PubMed ID: 14566829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignant neoplasms and cardiovascular disease following radiotherapy.
    Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
    Health Phys; 2014 Feb; 106(2):229-46. PubMed ID: 24378498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT).
    Casey DL; Friedman DN; Moskowitz CS; Hilden PD; Sklar CA; Wexler LH; Wolden SL
    Pediatr Blood Cancer; 2015 Feb; 62(2):311-316. PubMed ID: 25328040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased stomach cancer risk following radiotherapy for testicular cancer.
    Hauptmann M; Fossa SD; Stovall M; van Leeuwen FE; Johannesen TB; Rajaraman P; Gilbert ES; Smith SA; Weathers RE; Aleman BM; Andersson M; Curtis RE; Dores GM; Fraumeni JF; Hall P; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Lynch CF; Pukkala E; Storm HH; Vaalavirta L; van den Belt-Dusebout AW; Travis LB; Morton LM
    Br J Cancer; 2015 Jan; 112(1):44-51. PubMed ID: 25349972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects.
    Inskip PD; Sigurdson AJ; Veiga L; Bhatti P; Ronckers C; Rajaraman P; Boukheris H; Stovall M; Smith S; Hammond S; Henderson TO; Watt TC; Mertens AC; Leisenring W; Stratton K; Whitton J; Donaldson SS; Armstrong GT; Robison LL; Neglia JP
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):800-7. PubMed ID: 26972653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.